These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26235807)

  • 1. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
    Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
    Satriyo PB; Su CM; Ong JR; Huang WC; Fong IH; Lin CC; Aryandono T; Haryana SM; Deng L; Huang CC; Tzeng YM; Chao TY; Liu HW; Yeh CT
    Toxicol Appl Pharmacol; 2021 Jul; 422():115493. PubMed ID: 33727089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
    Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Acetylantroquinonol B from antrodia cinnamomea enhances immune function of dendritic cells against liver cancer stem cells.
    Li TY; Chiang BH
    Biomed Pharmacother; 2019 Jan; 109():2262-2269. PubMed ID: 30551483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
    Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression.
    Bamodu OA; Yang CK; Cheng WH; Tzeng DTW; Kuo KT; Huang CC; Deng L; Hsiao M; Lee WH; Yeh CT
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30103475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model.
    Wu CH; Ou CH; Yen IC; Lee SY
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.
    James MI; Iwuji C; Irving G; Karmokar A; Higgins JA; Griffin-Teal N; Thomas A; Greaves P; Cai H; Patel SR; Morgan B; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Howells LM; Brown K
    Cancer Lett; 2015 Aug; 364(2):135-41. PubMed ID: 25979230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
    Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
    Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
    Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.
    Munakata K; Uemura M; Tanaka S; Kawai K; Kitahara T; Miyo M; Kano Y; Nishikawa S; Fukusumi T; Takahashi Y; Hata T; Nishimura J; Takemasa I; Mizushima T; Ikenaga M; Kato T; Murata K; Carethers JM; Yamamoto H; Doki Y; Mori M
    Clin Cancer Res; 2016 Nov; 22(21):5277-5286. PubMed ID: 27166395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.